Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6131 studies found for:    (Ear OR Nose OR Throat) AND Conditions
Show Display Options
Rank Status Study
1 Completed A Comparison of microRNA Samples in Patients With Nasal Polyps and Aspirin Exacerbated Respiratory Disease and Those With Nasal Polyps Only
Conditions: Aspirin-exacerbated Respiratory Disease;   Nasal Polyp
Intervention: Genetic: microRNA
2 Completed
Has Results
A Clinical Trial of Anakinra for Steroid-Resistant Autoimmune Inner Ear Disease
Conditions: Sensorineural Hearing Loss;   Autoimmune Inner Ear Disease
Intervention: Drug: Anakinra
3 Recruiting Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease
Condition: Meniere's Disease
Intervention: Drug: Gadolinium
4 Recruiting Association Between a Mother's Exposure to "Strep Throat" and Her Baby's Developing Heart Disease
Condition: Congenital Heart Disease in Pregnancy
Intervention:
5 Completed The Effects of Gevokizumab in Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease
Condition: Autoimmune Inner Ear Disease
Intervention: Drug: gevokizumab
6 Recruiting The Nasal Airway in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Other: Upper airway assessment, including nasal biopsy
7 Completed Conditions of Diagnostic Panendoscopy of the Upper Airway Under Propofol Remifentanil General Anesthesia
Condition: Tumor of Ear, Nose and Throat
Intervention: Drug: Remifentanil
8 Unknown  Taste Disorders in Middle Ear Disease and After Middle Ear Surgery
Condition: Taste Disturbance
Interventions: Other: taste measurement;   Other: Symptom questionnaire;   Behavioral: Quality of life questionnaire;   Other: Nerve sample
9 Recruiting Infant Nasal Nitric Oxide Levels in Congenital Heart Disease
Condition: Congenital Heart Disease
Intervention: Device: Measurement of nasal Nitric Oxide level
10 Recruiting Breath Analysis Using an Electronic Nose in Non Alcoholic Fatty Liver Disease
Condition: Non-alcoholic Fatty Liver Disease
Intervention: Device: Breath analysis - electronic signature "Breath-print"
11 Terminated Intratympanic Injection for Autoimmune Inner Ear Disease
Condition: Autoimmune Inner Ear Disease
Intervention: Drug: Golimumab
12 Completed Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)
Condition: Coat's Disease
Intervention: Drug: anecortave acetate
13 Recruiting TransMEM Gas Exchange -- Project 1, Aim 2
Conditions: Middle Ear Disease;   Nasal Allergy
Interventions: Biological: ragweed;   Biological: histamine;   Drug: pseudoephedrine;   Drug: Oxymetazoline
14 Enrolling by invitation Evaluation of a Lightweight Nasal Interface and Ventilator in Patients With Respiratory Disease
Conditions: Chronic Obstructive Lung Disease;   Interstitial Lung Disease
Interventions: Device: Tidal Assist Ventilator System;   Device: Nasal Cannula Oxygen
15 Completed Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD)
Condition: Social Anxiety Disorder
Interventions: Drug: PH94B;   Other: Placebo
16 Completed Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy
Conditions: Coats' Disease;   Idiopathic Retinal Telangiectasia;   Retinal Angiomatous Proliferation;   Polypoidal Choroidal Vasculopathy;   Pseudoxanthoma Elasticum;   Pathological Myopia;   Multi-focal Choroiditis;   Rubeosis Iridis;   Von Hippel Lindau Disease;   BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL (Disorder)
Intervention: Drug: ranibizumab injection (0.5 mg)
17 Completed Nanotechnology for Detection of Multiple Sclerosis Compared to Autoimmune and Neurological Diseases by Exhaled Samples
Condition: Multiple Sclerosis
Intervention: Other: NA-NOSE artificial olfactory system
18 Unknown  Compare the Effects of Fluticasone Furoate Nasal Spray vs Placebo in Patients With Nasal Polypoid Disease
Condition: Patients With Nasal Polyps
Interventions: Drug: fluticasone furoate;   Other: placebo
19 Completed Intestinal and Nasal Microbiota of Patients With Idiopathic Parkinson's Disease
Condition: Parkinson's Disease
Intervention:
20 Completed Effects of an Oxymizer on Endurance Time in Patients With Chronic Lung Diseases
Conditions: COPD;   Interstitial Lung Disease
Interventions: Device: Oxymizer;   Device: conventional nasal cannula

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.